SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

NCT00365274 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

NIH

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma

Interventions

DRUG: Cyclophosphamide
DRUG: Doxorubicin hydrochloride
DRUG: vincristine sulfate
DRUG: prednisone
DRUG: SGN-30

Sponsor

National Cancer Institute (NCI)